GlassScriptPhysician profile
Krista H King
NPI 1053372136
$818.66
in general payments reported to CMS, 2019-2025
14 companies · $23.41 in 2025
The $23.41 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.04 · 2020: $117 · 2021: $309 · 2022: $308 · 2025: $23.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $23.41.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $23.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $271.75 | 2021-2022 | |
| Novo Nordisk INC | $129.94 | 2020-2022 | |
| Glaxosmithkline, LLC. | $84.45 | 2019-2025 | Shingrix, Arexvy |
| Gilead Sciences, INC. | $74.32 | 2020 | |
| Merck Sharp & Dohme LLC | $69.96 | 2020-2022 | |
| Abbott Laboratories | $34.35 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $29.75 | 2022 | |
| Almatica Pharma LLC | $28.61 | 2022 | |
| Bausch Health US, LLC | $28.23 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.43 | 2022 | |
| Eisai INC. | $14.63 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $13.99 | 2021 | |
| Astellas Pharma US INC | $11.95 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krista King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.